Of the 26 drugs in phase three of clinical trials as of July 2019, 13 of them were drugs that target neurotransmitters in the brain such as acetylcholine and glutamate. This statistic depicts the number of Alzheimer's drugs in phase three of clinical trials, by mechanism of action.
Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BioSpace. (September 23, 2019). Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/
BioSpace. "Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action." Chart. September 23, 2019. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/
BioSpace. (2019). Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action. Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/
BioSpace. "Number of Alzheimer's Drugs in Phase 3 of Clinical Trials as of July 2019, by Mechanism of Action." Statista, Statista Inc., 23 Sep 2019, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/
BioSpace, Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/ (last visited November 13, 2024)
Number of Alzheimer's drugs in phase 3 of clinical trials as of July 2019, by mechanism of action [Graph], BioSpace, September 23, 2019. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1093331/alzheimers-phase-3-drugs-by-mechanism-of-action-us/
